Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 26 September 2016

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Endoscopic ultrasound in suspected biliary obstruction influences ERCP burden in real clinical practice

A study in this month's issue of the European Journal of Gastroenterology & Hepatology reports on the diagnostic accuracy of endoscopic ultrasound in suspected biliary obstruction and its impact on ERCP burden in real clinical practice.

News image

Performing endoscopic ultrasound before endoscopic retrograde cholangiopancreatography (ERCP) has been described to be useful in cases of suspected biliary obstruction where endoscopic ultrasound can triage patients for endoscopic retrograde cholangiopancreatography.

Dr Zaheer Abdula and colleagues determined the diagnostic accuracy of endoscopic ultrasound and its impact on endoscopic retrograde cholangiopancreatography burden in real clinical practice.

The research team evaluated the safety and efficacy of endoscopic ultrasound+endoscopic retrograde cholangiopancreatography in a single endoscopic session.

The team evaluated 418 consecutive patients with suspected but unexplained biliary obstruction referred for endoscopic ultrasound before possible endoscopic retrograde cholangiopancreatography.

The research team team determined the diagnostic accuracy of endoscopic ultrasound and its value in predicting the need for endoscopic retrograde cholangiopancreatography.

Endoscopic ultrasound established whether pancreaticobiliary disorder was present, and whether therapeutic endoscopic retrograde cholangiopancreatography was required.

Endoscopic ultrasound showed pathology in 42% who had a nondilated biliary system
European Journal of Gastroenterology & Hepatology

These decisions were matched with endoscopic retrograde cholangiopancreatography findings, histology, clinical course, and follow-up.

Where endoscopic retrograde cholangiopancreatography was indicated, it was performed in the same endoscopic session.

Endoscopic ultrasound was performed in 412 out of 418 patients, and endoscopic retrograde cholangiopancreatography was considered necessary in 64%.

The research team noted that the single-session endoscopic ultrasound, and endoscopic retrograde cholangiopancreatography was safe and effective.

The diagnostic accuracy of endoscopic ultrasound included 99% in choledocholithiasis, 90% with malignant strictures, and 92% with benign strictures.

The research team reported that endoscopic ultrasound showed pathology in 42% of patients who had a nondilated biliary system at initial investigations.

When endoscopic ultrasound indicated a normal common bile duct, this had a 100% positive predictive value for non-necessity for endoscopic retrograde cholangiopancreatography.

The median overall follow-up period was 12 months.

Dr Abdula's team commented, "Endoscopic ultrasound demonstrated high diagnostic accuracy in this mixed group of pancreaticobiliary disorder."

"This accurately guided endoscopic retrograde cholangiopancreatography need and avoided unnecessary endoscopic retrograde cholangiopancreatography in 36%."

"endoscopic ultrasound and endoscopic retrograde cholangiopancreatography in the same endoscopic session for the evaluation and management of PBD is technically feasible, with safety and efficacy profiles equivalent to that of each procedure performed independently in different sessions."

Eur J of Gastroenterol & Hepatology: 2013: (25)7 :850-857
21 June 2013

Go to top of page Email this page Email this page to a colleague

 26 September 2016 
Preventing cirrhosis in Hep C with fibrosis
 26 September 2016 
Body image after abdominoperineal excision for rectal cancer
 26 September 2016 
Gastric cancer risk in intestinal metaplasia of the stomach
 23 September 2016 
Sleep quality in nonalcoholic cirrhotic patients
 23 September 2016 
Exercise for NAFLD
 23 September 2016 
BMI history and fatty liver
 22 September 2016 
Predicting small-bowel Crohn’s disease
 22 September 2016 
Colectomy outcomes for ulcerative colitis
 22 September 2016 
Technology vs intervention for weight loss
 21 September 2016 
Cardiopulmonary exercise testing in liver transplant candidates
 21 September 2016 
Employment status and IBD
 21 September 2016 
Patients vs providers on nutrition in IBD
 20 September 2016 
Improving healthcare systems for viral Hepatitis
 20 September 2016 
GI benefits of COX-2 selective inhibitors
 20 September 2016 
Predicting relapse in Crohn's
 19 September 2016 
Prevalence of esophageal cancer in Barrett's
 19 September 2016 
Fecal microbiota transplantation and CDI in IBD
 19 September 2016 
Antibiotic resistance in Helicobacter pylori
 16 September 2016 
Low-residue diet before colonoscopy and bowel cleansing
 16 September 2016 
Genome-wide association in gastric cancer
 16 September 2016 
H. pylori in children with asthma
 15 September 2016 
Improving survival in cholangitis-associated septic shock
 15 September 2016 
Colorectal cancer survival and hospital volumes
 15 September 2016 
Primary sclerosing cholangitis and IBD
 14 September 2016 
Intestinal malabsorption and olmesartan
 14 September 2016 
Infection reduction strategy after colorectal resection
 14 September 2016 
Predicting long-term infliximab use in Crohn's
 13 September 2016 
Predicting survival in refractory celiac disease
 13 September 2016 
Cancer risk stratification in Barrett’s
 13 September 2016 
Screening vs non-screening colonoscopy
 12 September 2016 
Screening in familial colorectal cancer
 12 September 2016 
Metformin improves survival in pancreatic ductal cancer
 12 September 2016 
Consent guidelines for GI endoscopy procedures
 09 September 2016 
Development of IBS
 09 September 2016 
Safe and effective treatment for NASH
 09 September 2016 
Scale for stool measurement in diarrhea-IBS
 08 September 2016 
Prognostic factors for infliximab in Crohn's
 08 September 2016 
Chronic Hep B vs chronic Hep C and mortality
 08 September 2016 
Hematological malignancies in IBD
 07 September 2016 
IBD relapse during pregnancy
 07 September 2016 
New treatments for ulcerative colitis
 07 September 2016 
Alternative to nucleic acid testing in HCV
 06 September 2016 
Endoscopy clinic no-shows
 06 September 2016 
Risk of infection after elective colorectal surgery
 06 September 2016 
EHealth technologies in IBD
 05 September 2016 
Esophageal impedance monitoring
 05 September 2016 
Family history and IBD clinical course
 05 September 2016 
Biomarker for IBD and GI cancer
 02 September 2016 
Dietary carbohydrate intake, insulin resistance and GERD 
 02 September 2016 
Postpolypectomy bleeding in the colorectum
 02 September 2016 
Postop recurrence of Crohn's
 01 September 2016 
Prognostic test for liver transplants
 01 September 2016 
Recovery after colorectal surgery in elderly patients
 01 September 2016 
Obesity and post-ERCP pancreatitis
 30 August 2016 
NAFLD and carotid atherosclerosis
 30 August 2016 
Quality improvement program after colorectal surgery
 30 August 2016 
Gut microbial diversity in smokers with Crohn's
 29 August 2016 
Reducing Hep B-related HCC
 29 August 2016 
Hep B immunization of infants for liver cancer
 29 August 2016 
Risk factor for post-ERCP pancreatitis

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2016 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us